Larson Financial Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
2,721
-2,312
| -46% | -$181K | 0.01% | 644 |
|
|
2025
Q1 | $365K | Buy |
5,033
+1,618
| +47% | +$117K | 0.02% | 473 |
|
|
2024
Q4 | $253K | Sell |
3,415
-976
| -22% | -$72.3K | 0.01% | 508 |
|
|
2024
Q3 | $290K | Buy |
4,391
+2,923
| +199% | +$193K | 0.02% | 476 |
|
|
2024
Q2 | $136K | Buy |
1,468
+1,444
| +6,017% | +$133K | 0.01% | 568 |
|
|
2024
Q1 | $2.29K | Hold |
24
| – | – | ﹤0.01% | 1338 |
|
|
2023
Q4 | $1.83K | Sell |
24
-62
| -72% | -$4.73K | ﹤0.01% | 1380 |
|
|
2023
Q3 | $5.96K | Buy |
86
+70
| +438% | +$4.85K | ﹤0.01% | 1127 |
|
|
2023
Q2 | $1.51K | Sell |
16
-75
| -82% | -$7.07K | ﹤0.01% | 1315 |
|
|
2023
Q1 | $7.53K | Buy |
91
+45
| +98% | +$3.72K | ﹤0.01% | 997 |
|
|
2022
Q4 | $3.43K | Buy |
+46
| New | +$3.43K | ﹤0.01% | 1104 |
|
|
2022
Q2 | – | Sell |
-30
| Closed | -$4K | – | 1214 |
|
|
2022
Q1 | $4K | Hold |
30
| – | – | ﹤0.01% | 817 |
|
|
2021
Q4 | $4K | Buy |
+30
| New | +$4K | ﹤0.01% | 851 |
|
|
2020
Q1 | – | Sell |
-30
| Closed | -$2K | – | 567 |
|
|
2019
Q4 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 444 |
|